Articoli su riviste con comitato di redazione internazionale
(periodo 1999-1996)
1. Zoccali C. Calcium channel blockers in diabetic subjects: innocent
at last? Diabetes Nutr Metab. 1999 Aug;12(4): 249-51. Review.
2. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cottini E,
Giacone G, Malatino L. Prediction of left ventricular geometry by
clinic,
pre-dialysis and 24-h ambulatory BP monitoring in
hemodialysis patients: CREED investigators. J Hypertens. 1999
17(12 Pt 1): 1751-1758.
3. Zoccali C.
An evidence-based nephrology column in the JN.
J Nephrol. 1999, 12 (5): 312-3.
4. Malatino LS, Benedetto FA, Mallamaci F, Tripepi G, Zoccali C,
Parlongo S, Cutrupi S, Marino C, Panuccio V, Garozzo M,
Candela V, Bellanuova I, Cataliotti A, Rapisarda F, Fatuzzo P,
Bonanno G, Seminara G, Stancanelli B, Tassone F, Labate C.
Smoking,
blood pressure and serum albumin are major
determinants of carotid atherosclerosis in dialysis patients. CREED
Investigators. Cardiovascular Risk Extended Evaluation in Dialysis
patients. J Nephrol. 1999, 12(4): 256-260.
5. Ruggenenti P, Perna A, Gherardi G, Garini G, Zoccali C,
Salvadori M, Scolari F, Schena FP, Remuzzi G. Renoprotective
properties of ACE-inhibition in non-diabetic nephropathies with
non-nephrotic proteinuria. Lancet. 1999 31;354 (9176): 359-64.
6. Noris M, Ruggenenti P, Perna A, Orisio S, Caprioli J, Skerka C,
Vasile B, Zipfel PF, Remuzzi G. Hypocomplementemia discloses
genetic predisposition to hemolytic uremic syndrome and
thrombotic thrombocytopenic purpura: role of factor H
abnormalities. Italian Registry of Familial and Recurrent Hemolytic
Uremic Syndrome/Thrombotic Thrombocytopenic Purpura with
C. Zoccali. J Am Soc Nephrol 1999 10: 281-293.
7. Zoccali C. Evidence-based medicine: the clinician's perspective.
Nephrol Dial Transplant. 1999, 14: 42-5. Review.
8. Ruggenenti P, Perna A, Benini R, Bertani T, Zoccali C, Maggiore
Q, Salvadori M, Remuzzi G. In chronic nephropathies prolonged
ACE inhibition can induce remission: dynamics of time-dependent
changes in GFR. Investigators of the GISEN Group. Gruppo
Italiano Studi Epidemiologici in Nefrologia. J Am Soc Nephrol.
1999, 10: 997-1006.
9. Zoccali C,
Tripepi G.
Ambulatory monitoring and clinic BP
measurements for predicting left ventricular mass in patients with
chronic renal diseases. Nephrol Dial Transplant. 1999, 14: 240241.
10. C. Zoccali, G. Tripepi, B. Tucker, A. Johnston and LRI Baker.
Ambulatory monitoring and clinic BP measurements for predicting
left ventricular mass in patients with chronic renal diseases.
Nephrol Dial Transplant 1998; 14 (1): 240-241 (letter).
11. Zoccali C. Medical knowledge, quality of life and accreditation of
quality in health care. The perspective of the clinical nephrologist.
Int J Artif Organs. 1998, 21 (11): 717-720.
12. CREED investigators and C.
Zoccali.
C-reactive protein and
aterosclerosis in dialysis patients. Nephrol Dial Transplant 1998;
13, (10): 2710-2711 (letter).
13. Mallamaci F, Zoccali C, Parlongo S, Cutrupi S, Tripepi G,
Postorino M. Plasma adrenomedullin during acute changes in
intravascular volume in hemodialysis patients. Kidney Int. 1998,
54 (5):1697-1703.
14. GISEN with the participation of C. Zoccali and E. Oliva. Effects of
dihydropyridine calcium blockers, angiotensin-converting enzyme
inhibition and blood pressure control on chronic, non diabetic
nephropathy. J Am Soc Nephrol 1998, 9: 2096-2121.
0.821
3.039
1.009
1.009
10.197
6.182
1.752
6.182
1.752
1.754
1.063
1.754
3.781
6.361
15. GISEN with the participation of C. Zoccali and E. Oliva. Renal
function and requirement for dialysis in chronic nephropathy
patients on long – term Ramipril: REIN follow-up trial. Lancet 1998,
352: 1252-1256.
16. GISEN with the participation of C. Zoccali and E. Oliva. Urinary
protein excretion rate is the best indipendent predictor of ESRF in
non-diabetic proteinuric chronic nephropathy. Kidney Int 1998, 53:
1209-1216.
17. GISEN with the participation of C. Zoccali and E. Oliva. Proteinuria
predicts end-stage renal failure in non-diabetic chronic
nephropathy. Kidney Int 1998, (suppl 63): S54-57.
18. C. Zoccali, A. Giangrande. Foreword. Int J of Art Org 1998, 21: 716.
19. Panuccio V, Enia G, Crucitti S, Pustorino M, Biondo A, Zoccali C.
Another 'epidemic' of spontaneous rupture of peritoneal catheters.
Nephron. 1998, 79 (3): 359.
20. Zoccali C. Nocturnal hypoxemia: a cardiovascular risk factors in
dialysis patients. Seminars in dialysis 1998, 11: 264-266.
21. Zoccali C, Benedetto FA, Tripepi G, Cambareri F, Panuccio V,
Candela V, Mallamaci F, Enia G, Labate C, Tassone F. Nocturnal
hypoxemia, night-day arterial pressure changes and left ventricular
geometry in dialysis patients. Kidney Int. 1998, 53(4): 1078-84.
22. Zoccali C, Postorino M. Electronic publishing: now and tomorrow.
Nephrol Dial Transplant. 1998, 13: 25-29.
23. Ruggenenti P, Perna A, Mosconi L, Matalone M, Garini G, Salvadori
M, Zoccali C, Scolari F, Maggiore Q, G. Remuzzi. Randomized
placebo –controlled
trial of effect of ramirpil on decline in
glomerular filtration rate and risk of terminal renal failure in
proteinuricm non diabetic nephropathy. Lancet 1997, 28: 18571863.
24. Enia G, Garozzo M, Zoccali C. Lactic acidosis induced by
phenformin is still a public health problem in Italy. British Medical
Journal 1997, 29, 315(7120): 1466-7.
25. Mallamaci F, Zoccali C, Messineo L, Parlongo S, Postorino M. The
influence of volume depletion and central hypovolemia on the
plasma concentration of parathyroid hormone in dialysis patients.
J Am Soc Nephrol. 1997, 8(10): 1574-1578.
26. Zoccali C. Salt, resting arterial pressure and 24 h monitoring.
J Hypertens. 1997, 15(4): 458.
27. Italian Group of Renal Immunopathology with the partecipation of
C. Martorano and C. Zoccali. Survey of the Italian Registry of Renal
biopsies. Frequency of the renal disease for seven consecutive years.
Nephrol Dial Transplant 1997, 12: 418-426.
28. V. Panuccio, G. Enia, D. Pustorino, A. Biondo, S. Crucitti, C.
Zoccali. Exit site infection in peritoneal dialysis patients: prevalence
in a single center and evaluation of a nursing chart. Dialysis &
Transplantation 1997, 26: 143.
29. Zoccali C, Tripepi G, Mallamaci F, Panuccio V. The heart rate
response pattern to dialysis hypotension in haemodialysis patients.
Nephrol Dial Transplant. 1997, 12(3): 519-523.
30. Zoccali C, Mallamaci F, Cuzzola F. Does ambulatory monitoring
make saltier salt sensitivity studies? J Hypertens. 1997, 15(1): 100101.
31. Zoccali C,
Valvo E,
Russo D,
Panichi V,
Zuccala' A.
Antiproteinuric effect of Losartan in patients with chronic renal
diseases. Nephrol Dial Transplant. 1997, 12(1): 234-235.
32. Zoccali C, Mallamaci F, Cuzzola F, Leonardis D. Reproducibility
of the response to short-term low salt intake in essential
hypertension. J Hypertens. 1996, 14 (12): 1455-1459.
33. Zoccali C,
Mallamaci F.
Salt intake and hyperfiltration.
11.793
3.781
3.781
1.063
1.561
1.465
3.781
1.754
16.135
4.994
6.121
2.801
1.682
0.494
1.682
2.801
1.682
2.611
4.736
Hypertension. 1996, 28(6): 1100-1102.
34. Schena FP, Zoccali C. Bibliometric analysis of the scientific
productivity of the Italian Society of Nephrology for a period of five
consecutive years (1990-1994). Nephrol Dial Transplant. 1996,
11(11): 2359-2360.
35. G. Tripepi, F. Mallamaci, C. Zoccali. The alarm reaction to blood
pressure measurement in dialysis patients.
Contrib. Nephrol.
Basel, Karger, 1996, vol. 119, pp 161-164.
36. F. Mallamaci, G. Tripepi, V. Panuccio, F. Pennisi, F.
Benedetto,
C.
Zoccali.
Neurohumoral response to volume
depletion and central hypovolemia in dialysis patients. Contrib.
Nephrol. Basel, Karger 1996, vol. 119 pp 189-196.
37. Mallamaci F, Leonardis D, Bellizzi V, Zoccali C. Does high salt
intake cause hyperfiltration in patients with essential hypertension?
J Hum Hypertens. 1996, 10(3): 157-161.
38. Zoccali C, Mallamaci F. Failure of AVP and other pressor hormones
to increase in severe recurrent dialysis hypotension. Nephrol Dial
Transplant. 1996, 11(2): 402-403.
39. Panuccio V, Enia G, Parlongo S, Cutrupi S, Zoccali C. Severe
rhabdomyolysis induced by a retard formulation of bezafibrate in a
CAPD patient. Nephron. 1996, 73(4): 736.
1.693
Without
impact
Without
impact
0.914
1.693
1.938